Iron-deficiency anemia (IDA) is a condition where objective iron deficiency is at the origin of the anemia. The World Health Organization (WHO) defines anemia as a hemoglobin value of < 120 g/l for nonpregnant women, and < 130 g/l for men. IDA is a very common condition, particularly in women. In industrialized countries, it is estimated that 23 % of pregnant women, 10 % of all women (15 -59 years), 4 % of men (15 -59 years) and 12 % of elderly individuals ≥ 60 years are anemic [1] . IDA is commonly (62 %) caused by chronic blood loss from the gastrointestinal tract. Peptic ulcerations are the commonest lesions found in the upper gastrointestinal tract, while cancers are one of the most common abnormalities discovered in the colon. Other causes of IDA include cumulative menstrual blood loss or pregnancy in premenopausal women, de-creased gastrointestinal absorption (malabsorption syndromes), and chronic intravascular hemolysis, among others. Lower gastrointestinal bleeding (LGIB) usually refers to blood loss originating from a lesion distal to the ligament of Treitz [2], even though approximately 10 % of patients with hematochezia may have an upper gastrointestinal source of bleeding [3, 4] .
Introduction ! Iron-deficiency anemia (IDA) is a condition where objective iron deficiency is at the origin of the anemia. The World Health Organization (WHO) defines anemia as a hemoglobin value of < 120 g/l for nonpregnant women, and < 130 g/l for men. IDA is a very common condition, particularly in women. In industrialized countries, it is estimated that 23 % of pregnant women, 10 % of all women (15 -59 years), 4 % of men (15 -59 years) and 12 % of elderly individuals ≥ 60 years are anemic [1] . IDA is commonly (62 %) caused by chronic blood loss from the gastrointestinal tract. Peptic ulcerations are the commonest lesions found in the upper gastrointestinal tract, while cancers are one of the most common abnormalities discovered in the colon. Other causes of IDA include cumulative menstrual blood loss or pregnancy in premenopausal women, de-creased gastrointestinal absorption (malabsorption syndromes), and chronic intravascular hemolysis, among others. Lower gastrointestinal bleeding (LGIB) usually refers to blood loss originating from a lesion distal to the ligament of Treitz [2] , even though approximately 10 % of patients with hematochezia may have an upper gastrointestinal source of bleeding [3, 4] .
LGIB may manifest itself as hematochezia (rectal bleeding: visible bright red or maroon blood per rectum), as opposed to melena (dark stools), which is most often a manifestation of upper gastrointestinal bleeding. Acute LGIB is of recent duration (< 3 days) and may result in hemodynamic instability, rapid hemoglobin decrease and/or the need for blood transfusion [5] . Chronic LGIB corresponds to the passage of blood per rectum over > 3 days. The patient with chronic bleeding may present with fecal occult blood (IDA and/or positive fecal occult blood test Background and study aims: To summarize the published literature on assessment of appropriateness of colonoscopy for the investigation of iron-deficiency anemia (IDA) and hematochezia, and report appropriateness criteria developed by an expert panel, the 2008 European Panel on the Appropriateness of Gastrointestinal Endoscopy, EPAGE II. Methods: A systematic search of guidelines, systematic reviews and primary studies regarding the evaluation and management of IDA and hematochezia was performed. The RAND/UCLA Appropriateness Method was applied to develop appropriateness criteria for colonoscopy for these conditions. Results: IDA occurs in 2 % -5 % of adult men and postmenopausal women. Examination of both the upper and lower gastrointestinal tract is recommended in patients with iron deficiency. Colonoscopy for IDA yields one colorectal cancer (CRC) in every 9 -13 colonoscopies. Hematoche-zia is a well-recognized alarm symptom and such patients are likely to be referred for colonoscopy. Colonoscopy is unanimously recommended in patients aged ≥ 50. Diverticulosis, vascular ectasias, and ischemic colitis are common causes of acute lower gastrointestinal bleeding (LGIB); CRC is found in 0.2 % -11 % of the colonoscopies performed for LGIB. Most patients with scant hematochezia have an anorectal or a distal source of bleeding. The expert panel considered most clinical indications for colonoscopy as appropriate in the presence of IDA (58 %) or hematochezia (83 %). Conclusion: Despite the limitations of the published studies, guidelines unanimously recommend colonoscopy for the investigation of IDA and hematochezia in patients aged ≥ 50 years. These indications were also considered appropriate by EPAGE II, as were indications in patients at low risk for CRC with no obvious cause of bleeding found during adequate previous investigations.
[FOBT]), intermittent melena, or scant hematochezia [5] .
LGIB is mainly a problem of the elderly that reflects the growing incidence rate of colonic lesions associated with increasing age (e. g. polyps, diverticulosis, colorectal cancer and angiodysplasia) [2] . The prevalence of rectal bleeding (previous 12 months) in the general population may vary between 15 % and 30 % [6, 7] . Major causes of LGIB can be divided into the following categories: anatomical (e. g. diverticulosis), vascular (e. g. angiodysplasia, ischemic), inflammatory (e. g. inflammatory bowel disease [IBD], infectious), and neoplastic [8] . The most commonly diagnosed lesions are diverticulosis, angiodysplasia, and hemorrhoids. Other causes include colon polyps, colorectal cancer (CRC), and IBD. The occurrence of polyps, colorectal cancer, and diverticulosis increases with increasing patient age. Since hemorrhoids and diverticula are very common in the general population, it is difficult to relate the episode of bleeding to this type of lesion unless the bleeding site is unequivocally visualized during endoscopy. This is particularly true for young individuals (< 50 years) in whom hemorrhoids are a common cause of minor hematochezia. Though LGIB may have multiple causes, the major clinical concern is its association with CRC [9 -11] . In April 2008, a multidisciplinary European expert panel, EPAGE II, convened in Montreux, Switzerland, to discuss and develop criteria for the appropriate use of colonoscopy. This article presents the literature review on IDA and hematochezia provided to the panelists before the panel meeting, and also presents the panel's results. It is an update of a previous literature review and consideration of appropriateness criteria published in 1999 [12, 13] . The investigation of massive LGIB has not been addressed in this review since this category of patient presents different risk-factor, morbidity and mortality profiles. This review also does not address the investigation of obscure bleeding, melena, and FOBT, these issues being examined separately.
Methods

!
The literature review process included a systematic search of websites issuing guidelines and of Medline (1997 -February 2008) to select published guidelines, systematic reviews, and primary studies assessing the use of colonoscopy in patients with IDA or hematochezia. The literature published before 1997 is presented in the previous literature review [12, 13] . The targeted patients had IDA or hematochezia. Patients with IDA were supposed to have no malabsorption syndrome, were with or without upper or lower abdominal symptoms, were at average or increased risk of CRC, and a potential source of bleeding had or had not been investigated or possibly found. Patients with hematochezia were hemodynamically stable and free of IBD, at average or increased risk of CRC, with or without previous gastrointestinal investigations and possibly an identified source of bleeding; the presence of blood, either bright red or not, was also considered. The application of the RAND/UCLA Appropriateness Method is described in detail in a companion article in this issue [14] . Briefly, this process is a formal explicit panel method that allows classification of each indication into one of the following categories of appropriateness: inappropriate; uncertain; appropriate; appropriate and necessary (i. e. the indication mandates colonoscopy). To simplify the graphical presentation of the appropriateness results, these four categories were consolidated into two clusters:
"Appropriate" (appropriate, and appropriate and necessary) and "Not appropriate" (inappropriate, and uncertain). In addition to simplification and enhanced clarity of presentation, the rationale for this choice was that in many instances in the case of a non-appropriate scenario, whether it be uncertain or inappropriate, the decision for not proposing the colonoscopy should be specifically discussed and shared with the patient. All clinical indications and their ratings are available on the EPAGE website (www.epage.ch).
Results: Literature review !
Iron-deficiency anemia
All 17 primary studies published between January 1997 and February 2008 assessing the use of endoscopy in men and postmenopausal women with IDA were case studies or cross-sectional studies ( Table e1) (Table e1 ). Dual colonic and upper intestinal disease was reported in up to 29 % of the cases [19] . Based on these results, the majority of authors recommend upper and lower endoscopy for the investigation of IDA. If gastroscopy is performed first, most authors recommend colonoscopy regardless of the findings of the upper gastrointestinal endoscopy. Neither the use of nonsteroidal anti-inflammatory drugs (NSAIDs) nor the presence of gastrointestinal symptoms were consistently reported as being associated with abnormalities in the corresponding portion of the gastrointestinal tract. Studies reporting the prevalence of gastrointestinal lesions in persons with low ferritin levels but no anemia showed that gastrointestinal lesions and CRC were found in about 50 % and 5 % of the patients at endoscopy, respectively [32, 33] . The prevalence of colorectal cancer was higher for iron-deficient anemic, compared with iron-deficient nonanemic, patients [21] . In addition, ferritin levels of below 100 ng/mL were shown to be associated with an increased risk of CRC in anemic patients compared with those who were nonanemic [34] . In young women, excessive menstrual blood loss is generally considered to be the main cause of IDA. The diagnostic yield of endoscopy in premenopausal women with IDA was examined in 7 studies (Table e2 ) [24, 35 -40] . Concomitant upper and lower gastrointestinal lesions, including gastrointestinal malignancies, were discovered at a prevalence rate considered high enough to recommend bidirectional endoscopy for premenopausal women with IDA, particularly in those >40 years of age. However, gastrointestinal malignancy is rarely encountered in premenopausal women in the general population and indeed, in one US population-based cohort study, it was reported that none of the premenopausal women, with or without IDA, were diagnosed with gastrointestinal malignancy within 2 years of hemoglobin and iron measurement [41] . Authors of British and American guidelines generally advocate performing colonoscopy and upper endoscopy in men and women with IDA [42 -45] . Special consideration regarding premenopausal women and young men is given only by the British Society of Gastroenterology (BSG). The latter recommends both upper and lower endoscopy for asymptomatic premenopausal women with IDA aged ≥ 50 years, despite little existing data to support this. For women aged < 50 years, the BSG suggests performance of colonoscopy in the presence of colonic symptoms, a strong family history of CRC, or persistent IDA following iron supplementation and correction of potential causes of loss [44] . Young men with IDA should be investigated in the same way as for older men [44] .
Hematochezia
The diagnostic yield of colonoscopy in LGIB was assessed in 17 primary studies published between 1997 and February 2008 (Table e3) [46 -62] . Hemorrhoids (and anal fissures) are the most commonly found lesions in patients presenting with recurrent LGIB. The association between the presence of hemorrhoids and other significant lesions is unclear; even though the presence of anal disease did not exclude the presence of significant colonic lesions [62] , others found no association between the presence of anal lesions and diagnosis of neoplasm in young patients [54] . Cancer was found in 0.2 % -11 % of the colonoscopies performed for lower gastrointestinal bleeding. Polyps were found in 2 % -21 %, angiodysplasia in 1 % -5 %, and inflammatory bowel disease in 2 % -21 % of the patients. Finally, even if results were sometimes stratified according to age [49, 51, 55, 57] , only three studies specifically targeted patients < 50 years [54, 59, 62] ; although rare overall, cancers and other significant proximal lesions were also found in young patients [49, 55, 57 -60] . The American Society of Gastrointestinal Endoscopy (ASGE) recommends colonoscopy for patients aged > 50 years with scant hematochezia. In young healthy patients (≤ 40 years of age), after an initial evaluation including a digital rectal examination and sigmoidoscopy with or without anoscopy, colonoscopy is generally not considered necessary if a convincing benign source of bleeding (hemorroids, anal fissures) is found [5] . In cases of isolated rectal bleeding, French guidelines (ANAES) recommend complete colonoscopy for patients aged ≥ 50 years, but do not favor colonoscopy rather than sigmoidoscopy for those aged < 50 years [63] . However, colonoscopy is recommended by the ANAES Table 4 Definition of terms used to characterize clinical indications for the use of colonoscopy in patients with iron-deficiency anemia (IDA) or hematochezia.
Term Definition
Iron-deficiency anemia For IDA, • " Fig. 1 a shows the color-coded panel results as a simplified dichotomy: "Not appropriate" (inappropriate, or uncertain), versus "Appropriate" (appropriate and possibly necessary). Terms used for the definition of these scenarios are listed in• " Table 4 . The intentionally simplified version shown in • " Fig. 1 a mainly reveals that colonoscopy is appropriate, and for some situations even necessary, in patients ≥ 50 years with IDA, in women without gynecological reasons for IDA, and in men < 50 years with lower abdominal symptoms without prior gastrointestinal investigations, or with prior investigations which did not reveal the origin of IDA. Fig. e1b is a more detailed color-coded presentation of appropriateness results for IDA scenarios. In patients aged ≥ 50 years all indications were appropriate, and even necessary when a potential bleeding source had not been identified. In women < 50 years, for whom a possible gynecological cause of anemia was not excluded, all scenarios were considered inappropriate or uncertain, unless previous upper gastrointestinal endoscopy or flexible sigmoidoscopy had failed to reveal a potential source of bleeding in the presence of lower abdominal symptoms. In men < 50 years and women < 50 years in whom a gynecological cause had already been excluded, colonoscopy was deemed appropriate in the presence of lower abdominal symptoms in most scenarios, whereas in the absence of lower abdominal symptoms, all scenarios were inappropriate or uncertain, unless a potential source of bleeding had not been revealed by prior gastrointestinal investigations. For hematochezia,• " Fig. 2 a shows the color-coded panel results as a simplified dichotomy: "Not appropriate" (inappropriate or uncertain), versus "Appropriate" (appropriate and possibly necessary). In patients ≥ 50 years, colonoscopy was deemed appropriate in almost all scenarios. In patients < 50 years, colonoscopy was appropriate in the presence of any risk factors for CRC, as well as in average-risk patients without bright red-blood hematochezia who had never undergone investigation, or in the case of normal flexible sigmoidoscopy. Fig. e2b shows detailed appropriateness criteria in hematochezia. Above age 50, and in the presence of any risk factor for CRC, almost all scenarios were considered appropriate and necessary. In patients aged <50 at average risk of colorectal cancer, colonoscopy was considered appropriate if a previous anoscopy or sigmoidoscopy did not reveal a potential source of bleeding, and as the first-line lower gastrointestinal investigation in the absence of bright red blood. In patients < 50 years with any risk factor for CRC, colonoscopy was considered appropriate in almost all situations. Conclusions ! Most of the published studies have limitations: some studies lacked a control group, which made it impossible to determine whether comparable lesions would have been detected in individuals with similar characteristics but without IDA or hematochezia; indeed, the vast majority of studies included are only case series; furthermore, selection bias may have occurred because individuals were mainly referred to specialized tertiary centers, which may have resulted in the selection of individuals with IDA or hematochezia who were sicker than those in the general population; and in addition, study populations were small. Conclusions are also limited by heterogeneity in the definition of anemia, patient inclusion and exclusion criteria (study population), the investigations performed, and the degree to which lesions are considered to be a potential cause of IDA or hematochezia. In addition, some authors also reported gastrointestinal lesions which were not responsible for IDA or hematochezia. Direct comparison of results between these studies is therefore difficult, and in consequence guidelines and recommendations based on these studies should be interpreted with caution. This review of the literature highlights the fact that despite the modest quality of evidence, colonoscopy is recommended in the investigation of almost all cases of IDA and hematochezia. It remains unclear, however, in patients < 50 years, whether the proportion of high-risk adenomas and cancers is high enough to systematically recommend the performance of colonoscopy, particularly in patients with hematochezia. A rigorous assessment of the appropriateness of colonoscopy in cases of IDA and hematochezia is needed, especially in young persons, as well as in cases where previously performed investigations identified a potential source of bleeding.
In summary. and in accordance with the literature review and clinical practice guidelines, the expert panel considered that IDA and hematochezia are undisputed indications for colonoscopy in patients aged > 50 years. In patients at lower risk of colorectal cancer (CRC), colonoscopy was in general only considered appropriate once potential sources of bleeding have been excluded by adequate gastrointestinal and nongastrointestinal investigations. In young patients (<40 years) with hematochezia, colonoscopy would probably not be recommended as the first-step investigation. Fig. e1b Appropriateness ratings of clinical indications for performing colonoscopy in patients with iron-deficiency anemia (IDA), with malabsorption syndrome excluded (full decision tree). GI, gastrointestinal. Fig. e2b Appropriateness ratings of clinical indications for performing colonoscopy in patients with hematochezia (without inflammatory bowel disease [IBD]), and who are hemodynamically stable (full decision tree). GI, gastrointestinal. Table e1 Studies assessing the use of endoscopy for the diagnostic work-up of iron deficiency anemia (IDA), in men and postmenopausal women. Table e2 Studies assessing the use of endoscopy for the diagnostic work-up of iron-deficiency anemia (IDA), in premenopausal women. Table e3 Studies assessing the use of colonoscopy for the diagnostic work-up of hematochezia.
